RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Total current assets

Edwards Lifesciences CorpEW

Market cap
$49.7B
P/E ratio
SummaryFinancials
Period EndTotal current assets (Million USD)YoY (%)
Dec 31, 20246,285+55.74%
Dec 31, 20234,036+30.36%
Dec 31, 20223,096-2.67%
Dec 31, 20213,181+2.90%
Dec 31, 20203,091+3.59%
Dec 31, 20192,984+30.48%
Dec 31, 20182,287-9.68%
Dec 31, 20172,532+13.04%
Dec 31, 20162,240+9.38%
Dec 31, 20152,048-10.75%
Dec 31, 20142,295+32.96%
Dec 31, 20131,726+33.59%
Dec 31, 20121,292+10.56%
Dec 31, 20111,169+13.16%
Dec 31, 20101,033

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)